Atypical 5′ splice sites cause CFTR exon 9 to be vulnerable to skipping

被引:27
作者
Hefferon, TW
Broackes-Carter, FC
Harris, A
Cutting, GR
机构
[1] Johns Hopkins Univ, Sch Med, McKusick Nathans Inst Genet Med, Baltimore, MD USA
[2] Johns Hopkins Univ, Sch Med, Predoctoral Training Program Human Genet & Mol Bi, Baltimore, MD USA
[3] Univ Oxford, John Radcliffe Hosp, Weatherall Inst Mol Med, Oxford OX3 9DU, England
基金
美国国家卫生研究院;
关键词
D O I
10.1086/341664
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
The molecular basis of the skipping of constitutive exons in many messenger RNAs is not fully understood. A well-studied example is exon 9 of the human cystic fibrosis transmembrane conductance regulator gene (CFTR), in which an abbreviated polypyrimidine tract between the branch point A and the 3 splice site is associated with increased exon skipping and disease. However, many exons, both in CFTR and in other genes and have short polypyrimidine tracts in their 3 splice sites, yet they are not skipped. Inspection of the 5 splice sites immediately up- and downstream of exon 9 revealed deviations from consensus sequence, so we hypothesized that this exon may be inherently vulnerable to skipping. To test this idea, we constructed a CFTR minigene and replicated exon 9 skipping associated with the length of the polypyrimidine tract upstream of exon 9. We then mutated the flanking 5 splice sites and determined the effect on exon skipping. Conversion of the upstream 5 splice site to consensus by replacing a pyrimidine at position +3 with a purine resulted in increased exon skipping. In contrast, conversion of the downstream 5 splice site to consensus by insertion of an adenine at position +4 resulted in a substantial reduction in exon 9 skipping, regardless of whether the upstream 5 splice site was consensus or not. These results suggested that the native downstream 5 splice site plays an important role in CFTR exon 9 skipping, a hypothesis that was supported by data from sheep and mouse genomes. Although CFTR exon 9 in sheep is preceded by a long polypyrimidine tract (Y-14), it skips exon 9 in vivo and has a nonconsensus downstream 5 splice site identical to that in humans. On the other hand, CFTR exon 9 in mice is preceded by a short polypyrimidine tract (Y-5) but is not skipped in vivo. Its downstream 5 splice site differs from that in humans by a 2-nt insertion, which, when introduced into the human CFTR minigene, abolished exon 9 skipping. Taken together, these observations place renewed emphasis on deviations at 5 splice sites in nucleotides other than the invariant GT, particularly when such changes are found in conjunction with other altered splicing sequences, such as a shortened polypyrimidine tract. Thus, careful inspection of entire 5 splice sites may identify constitutive exons that are vulnerable to skipping.
引用
收藏
页码:294 / 303
页数:10
相关论文
共 37 条
[21]   Higher proportion of intact exon 9 CFTR mRNA in nasal epithelium compared with vas deferens [J].
Mak, V ;
Jarvi, KA ;
Zielenski, J ;
Durie, P ;
Tsui, LC .
HUMAN MOLECULAR GENETICS, 1997, 6 (12) :2099-2107
[22]   Functional analysis of cis-acting elements regulating the alternative splicing of human CFTR exon 9 [J].
Niksic, M ;
Romano, M ;
Buratti, E ;
Pagani, F ;
Baralle, FE .
HUMAN MOLECULAR GENETICS, 1999, 8 (13) :2339-2349
[23]   Cellular and viral splicing factors can modify the splicing pattern of CFTR transcripts carrying splicing mutations [J].
Nissim-Rafinia, M ;
Chiba-Falek, O ;
Sharon, G ;
Boss, A ;
Kerem, B .
HUMAN MOLECULAR GENETICS, 2000, 9 (12) :1771-1778
[24]   Lung disease associated with the IVS8 5T allele of the CFTR gene [J].
Noone, PG ;
Pue, CA ;
Zhou, ZQ ;
Friedman, KJ ;
Wakeling, EL ;
Ganeshananthan, M ;
Simon, RH ;
Silverman, LM ;
Knowles, MR .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2000, 162 (05) :1919-1924
[25]   Congenital end-plate acetylcholinesterase deficiency caused by a nonsense mutation and an A→G splice-donor-site mutation at position+3 of the collagenlike-tail-subunit gene (COLQ):: How does G at position+3 result in aberrant splicing? [J].
Ohno, K ;
Brengman, JM ;
Felice, KJ ;
Cornblath, DR ;
Engel, AG .
AMERICAN JOURNAL OF HUMAN GENETICS, 1999, 65 (03) :635-644
[26]  
Osborne LR, 1994, PEDIATR PULM S, V10, P214
[27]   Splicing factors induce cystic fibrosis transmembrane regulator exon 9 skipping through a nonevolutionary conserved intronic element [J].
Pagani, F ;
Buratti, E ;
Stuani, C ;
Romano, M ;
Zuccato, E ;
Niksic, M ;
Giglio, L ;
Faraguna, D ;
Baralle, FE .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (28) :21041-21047
[28]  
Rogan PK, 1998, HUM MUTAT, V12, P153, DOI 10.1002/(SICI)1098-1004(1998)12:3<153::AID-HUMU3>3.3.CO
[29]  
2-O
[30]   RNA SPLICE JUNCTIONS OF DIFFERENT CLASSES OF EUKARYOTES - SEQUENCE STATISTICS AND FUNCTIONAL IMPLICATIONS IN GENE-EXPRESSION [J].
SHAPIRO, MB ;
SENAPATHY, P .
NUCLEIC ACIDS RESEARCH, 1987, 15 (17) :7155-7174